Dr. Parijatham Thomas, MD

Claim this profile

M D Anderson Cancer Center

Studies Ductal Carcinoma In Situ
Studies Breast cancer
2 reported clinical trials
4 drugs studied

Area of expertise

1

Ductal Carcinoma In Situ

Parijatham Thomas, MD has run 2 trials for Ductal Carcinoma In Situ. Some of their research focus areas include:

Stage I
HER2 positive
PR positive
2

Breast Cancer

Parijatham Thomas, MD has run 2 trials for Breast cancer. Some of their research focus areas include:

Stage I
HER2 positive
PR positive

Affiliated Hospitals

Image of trial facility.

M D Anderson Cancer Center

Image of trial facility.

University Of Texas MD Anderson Cancer Center

More about Parijatham Thomas, MD

Clinical Trial Related

7 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Parijatham Thomas, MD has experience with

  • Metformin Hydrochloride Extended Release
  • Nightly Fasting
  • Ruxolitinib
  • Surgery

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Parijatham Thomas, MD specialize in?

Is Parijatham Thomas, MD currently recruiting for clinical trials?

Are there any treatments that Parijatham Thomas, MD has studied deeply?

What is the best way to schedule an appointment with Parijatham Thomas, MD?

What is the office address of Parijatham Thomas, MD?

Is there any support for travel costs?